BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28182681)

  • 1. A standardized human embryoid body platform for the detection and analysis of teratogens.
    Flamier A; Singh S; Rasmussen TP
    PLoS One; 2017; 12(2):e0171101. PubMed ID: 28182681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Human Embryoid Bodies for Teratology.
    Flamier A; Singh S; Rasmussen TP
    Curr Protoc Toxicol; 2018 Feb; 75():13.13.1-13.13.14. PubMed ID: 29512128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput screen for teratogens using human pluripotent stem cells.
    Kameoka S; Babiarz J; Kolaja K; Chiao E
    Toxicol Sci; 2014 Jan; 137(1):76-90. PubMed ID: 24154490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
    Kuske B; Pulyanina PY; zur Nieden NI
    Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogen screening with human pluripotent stem cells.
    Worley KE; Rico-Varela J; Ho D; Wan LQ
    Integr Biol (Camb); 2018 Sep; 10(9):491-501. PubMed ID: 30095839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting human developmental toxicity of pharmaceuticals using human embryonic stem cells and metabolomics.
    West PR; Weir AM; Smith AM; Donley EL; Cezar GG
    Toxicol Appl Pharmacol; 2010 Aug; 247(1):18-27. PubMed ID: 20493898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced developmental toxicity test method based on embryoid body's area.
    Kang HY; Choi YK; Jo NR; Lee JH; Ahn C; Ahn IY; Kim TS; Kim KS; Choi KC; Lee JK; Lee SD; Jeung EB
    Reprod Toxicol; 2017 Sep; 72():74-85. PubMed ID: 28673813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphological observation of embryoid bodies completes the in vitro evaluation of nanomaterial embryotoxicity in the embryonic stem cell test (EST).
    Corradi S; Dakou E; Yadav A; Thomassen LC; Kirsch-Volders M; Leyns L
    Toxicol In Vitro; 2015 Oct; 29(7):1587-96. PubMed ID: 26093180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a molecular embryonic stem cell developmental toxicity assay.
    Panzica-Kelly JM; Brannen KC; Ma Y; Zhang CX; Flint OP; Lehman-McKeeman LD; Augustine-Rauch KA
    Toxicol Sci; 2013 Feb; 131(2):447-57. PubMed ID: 23042729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of drug induced developmental toxicity using human embryonic stem cells.
    Mehta A; Konala VB; Khanna A; Majumdar AS
    Cell Biol Int; 2008 Nov; 32(11):1412-24. PubMed ID: 18778783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the chick cardiomyocyte micromass system for identification of teratogens in a blind trial.
    Hurst H; Clothier RH; Pratten M
    Reprod Toxicol; 2009 Dec; 28(4):503-10. PubMed ID: 19646523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid.
    Eckardt K; Stahlmann R
    Arch Toxicol; 2010 Jan; 84(1):37-43. PubMed ID: 19856175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human pluripotent stem cell-based assay to predict developmental toxicity.
    Lauschke K; Rosenmai AK; Meiser I; Neubauer JC; Schmidt K; Rasmussen MA; Holst B; Taxvig C; Emnéus JK; Vinggaard AM
    Arch Toxicol; 2020 Nov; 94(11):3831-3846. PubMed ID: 32700165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation capacity by primary hepatocytes expands the applicability of the embryonic stem cell test as alternative to experimental animal testing.
    Hettwer M; Reis-Fernandes MA; Iken M; Ott M; Steinberg P; Nau H
    Reprod Toxicol; 2010 Aug; 30(1):113-20. PubMed ID: 20132877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'microEST' in vitro test for embryotoxicity - validated and endorsed or not?
    Combes RD
    Toxicol In Vitro; 2009 Mar; 23(2):360-1. PubMed ID: 19116163
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparing three novel endpoints for developmental osteotoxicity in the embryonic stem cell test.
    zur Nieden NI; Davis LA; Rancourt DE
    Toxicol Appl Pharmacol; 2010 Sep; 247(2):91-7. PubMed ID: 20576515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure.
    Colleoni S; Galli C; Gaspar JA; Meganathan K; Jagtap S; Hescheler J; Sachinidis A; Lazzari G
    Toxicol Sci; 2011 Dec; 124(2):370-7. PubMed ID: 21934132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual and combined developmental toxicity assessment of bisphenol A and genistein using the embryonic stem cell test in vitro.
    Kong D; Xing L; Liu R; Jiang J; Wang W; Shang L; Wei X; Hao W
    Food Chem Toxicol; 2013 Oct; 60():497-505. PubMed ID: 23948354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to "The microEST in vitro test for embryotoxicity - a case of mistaken identity?" by Robert Combes.
    Schwengberg S; Bohlen H; Fronhoff B
    Toxicol In Vitro; 2009 Mar; 23(2):362-3. PubMed ID: 19111605
    [No Abstract]   [Full Text] [Related]  

  • 20. Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells.
    Mayshar Y; Yanuka O; Benvenisty N
    J Cell Mol Med; 2011 Jun; 15(6):1393-401. PubMed ID: 20561110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.